Official launch of Spectrometer miniaturization project

Optical theory of miniature spectroscopic chips: Model establishment and theoretical verification.

The theory was recognized by the global optics community as the most difficult and challenging frontier problem to overcome.

Theoretical verification of miniature spectroscopic chip theory.

Initiation of the development of miniature spectroscopic chip manufacturing process.

Breakthrough in spectroscopic chip manufacturing process: Achieved high yield production.

Process precision: <1 nanometer, surpassing the current state-of-the-art semiconductor processes.

Spectrochip technology obtained multiple patents in the United States, China, and Taiwan.

SpectroChip Inc. was established.

Development and verification of the prototype of the SpectroChip color analysis instrument.

Obtained TFDA certification: Color analyzer, Clinical spectrophotometer and Immunoassay analyzer.

Conducted IRB research with major domestic hospitals, obtained actual clinical data verification, and achieved an accuracy rate of 99%.

Establishment of a database for 12 items of urine tests.

Prototype Release of the multi-functional analyzer, The ONE InstantCare.

Establishment of Covid-19 antibody testing database.

Collaboration with Kaohsiung Municipal Siaogang Hospital and Eternal Materials Co.,Ltd to form the "Medical Alliance".

Establishment of a Covid-19 neutralizing antibody testing database.

Cooperated with the University of Texas Medical Center to apply for EUA for clinical trials of Covid-19 neutralizing antibodies.

Launch of the Covid-19 corporate rapid screening project.

SpectroChip Enterprise Health Cloud Management platform went online.

The daily production capacity of the spectrochip increased to 100,000 pieces.

Establishment of databases for CK-MB and troponin I for cardiovascular disease detection and creatine and urine microprotein for kidney disease detection.

Development of a composite test kit for respiratory viruses FLU-A, FLU-B, and COVID-19.

Obtained the project manufacturing permit from the Ministry of Health and Welfare and the EDMA Code 15709008 permit from the European Union for COVID-19 SRBD antibody testing.

Collaboration with the Northern Medical Center in the United States for the Dengue fever testing big data research project.

Establishing a database for Dengue fever testing.

Collaboration with the Northern Medical Center for international precision medicine POCT projects.

Participation in the "Taiwan Precision Environmental Medicine Alliance" with Kaohsiung Municipal Siaogang Hospital and Kaohsiung Medical University.

Established the "Intelligent Medical Industry-Academia Alliance" with Kaohsiung Municipal Siaogang Hospital and Eternal Material.